2025-02-21 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Analysis

**0. Key Figures & Initial Observations:**

LLY, Eli Lilly and Co., is a leading pharmaceutical company.  Its significantly outperformed the S&P 500 (VOO) over the analyzed period.  The recent price action shows a slight downward trend, but the longer-term outlook remains positive based on provided data.


**1. Performance Comparison with S&P 500 (VOO):**

* **LLY Cumulative Return:** 611.98%
* **VOO Cumulative Return:** 121.84%
* **Return Difference:** 490.1%
* **Relative Divergence:** 78.1% (This indicates LLY's performance is significantly above the S&P 500's performance within the historical range of divergence.)


The table below shows that LLY's Compound Annual Growth Rate (CAGR) consistently surpassed that of the S&P 500 (implied by the large alpha values) over several years, exhibiting strong alpha and a relatively high beta, indicating higher volatility than the market.  Market capitalization has steadily increased.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 9.0% | 4.3% | -19.0% | 67.9 |
| 2016-2018  | 47.0% | 4.3% | 29.0% | 95.4 |
| 2017-2019  | 60.0% | 8.7% | 29.0% | 110.8 |
| 2018-2020  | 90.0% | 11.1% | 62.0% | 145.2 |
| 2019-2021  | 145.0% | 11.1% | 74.0% | 241.1 |
| 2020-2022  | 196.0% | 11.1% | 188.0% | 323.7 |
| 2021-2023  | 300.0% | 10.8% | 277.0% | 520.8 |
| 2022-2024  | 396.0% | 11.1% | 363.0% | 694.3 |
| 2023-2025  | 368.0% | 11.1% | 306.0% | 759.3 |


**2. Recent Price Action:**

* **Closing Price:** 844.27
* **5-Day Moving Average:** 864.60
* **20-Day Moving Average:** 818.80
* **60-Day Moving Average:** 792.88

The price is below all three moving averages, suggesting a short-term bearish trend.

**3. Technical Indicators:**

* **RSI:** 61.73 (Slightly above neutral; not overbought)
* **PPO:** 0.45 (Positive; suggesting bullish momentum)
* **20-Day Relative Divergence Change:** -4.9% (Short-term downward trend)
* **Expected Return (vs. S&P 500):** 105.1% (Significant outperformance expected over the long term)


**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue      |
|------------|--------|--------------|
| 2024-10-30 | 1.08   | 11.44 B$     |
| 2024-08-08 | 3.29   | 11.30 B$     |
| 2024-04-30 | 2.49   | 8.77 B$      |
| 2023-11-02 | -0.06  | 9.50 B$      |
| 2024-10-30 | -0.06  | 9.50 B$      |


There's significant variation in EPS.  Further investigation is needed to understand the drivers behind the fluctuations. Revenue shows relatively consistent performance, except for a lower figure in Q2 2024.  Duplicate entry for October 30, 2024, needs clarification.


**5. Financial Information:**

No "Total Revenue" or "Gross Profit" data was provided. This crucial information is needed for a comprehensive analysis.


**6. Overall Analysis:**

LLY has historically outperformed the S&P 500 significantly. While recent price action shows some short-term weakness,  the long-term outlook appears positive based on the high expected return and past performance.  However, the analysis is limited by the missing financial data (Total Revenue, Gross Profit) and inconsistencies in the earnings data.  Further investigation into the reasons for EPS fluctuations and the acquisition of complete financial statements are crucial for a more robust assessment of LLY's investment potential.  The substantial divergence from the market requires understanding the underlying drivers of this outperformance, which may involve factors not captured in the limited data.
